Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic pens arrive pre-loaded with exactly four weekly injections, each containing a fixed amount of the GLP-1 receptor agonist semaglutide. Understanding how these pens work, when doses increase, and what alternatives exist can help you make an informed decision about weight loss therapy and ongoing medication costs.
How Many Injections Are Actually in an Ozempic Pen?
Each Ozempic pen contains four individual, pre-filled weekly injections in a single disposable device. The pen is designed for once-weekly use, meaning one standard pen lasts exactly four weeks before needing replacement. This design simplifies adherence by removing the need to measure or mix doses yourself, as the pen delivers a consistent subcutaneous injection each time you use it.
The four injections within a single pen are not all identical in dose strength. Novo Nordisk manufactures pens at multiple dose levels (0.25 mg, 0.5 mg, 1 mg, and 2 mg per injection), and each pen contains four injections of the same strength. Patients typically begin on the lowest dose and switch to higher-strength pens as they progress through their treatment timeline, rather than varying doses within one pen.
The Weekly Injection Schedule and Dose Escalation Protocol
The standard Ozempic titration schedule runs for four weeks using 0.25 mg pens, followed by advancement to higher doses. Week one through four patients inject 0.25 mg once per week; at week five, they transition to 0.5 mg once weekly for four weeks. This gradual increase helps minimize gastrointestinal side effects and allows the body to adapt to semaglutide's mechanism of action on appetite regulation and blood glucose control.
Depending on individual tolerance and therapeutic goals, doses may escalate further to 1 mg or 2 mg weekly doses in subsequent weeks. Your prescribing clinician determines the pace of dose increases based on your response, side effect profile, and weight loss progress. The entire process requires purchasing new pens at each dose level change, as the four injections in each pen remain uniform in strength.
Cost Implications of Multiple Pens and Dose Changes
Brand-name Ozempic pens often cost $900 to $1,200 per pen without insurance, meaning a single four-week supply can exceed $1,000. Patients who progress through multiple dose levels over several months may spend thousands of dollars on pens before reaching their target maintenance dose. Additionally, insulin pens require specific sharps disposal containers and may generate waste as patients switch between strength levels.
PlexusDx offers compounded semaglutide injections starting at $149 per month, with pricing that remains flat regardless of dose escalation. This model eliminates the financial uncertainty of flat per-compound pricing and provides transparent, predictable monthly costs for patients pursuing long-term weight loss therapy. Compounded semaglutide from licensed 503A pharmacies delivers the same active ingredient in customizable doses, allowing seamless adjustments without purchasing new pens or paying premium prices at each step.
Compounded Semaglutide as a Practical Alternative
Compounded semaglutide injections prepared by licensed 503A compounding pharmacies offer dose flexibility that pre-filled pens cannot match. Rather than committing to four identical injections per pen, compounded formulations allow your prescriber to adjust your weekly dose by small increments, optimizing tolerability and minimizing side effect burden. This personalized approach often results in faster dose escalation and better clinical outcomes than rigid pen-based protocols.
PlexusDx provides access to compounded semaglutide injections across all 50 states without requiring insurance or membership fees. Patients can start treatment immediately with HSA or FSA funds, and those interested in genetic insights can add the Precision Peptide Genetic Test ($99) after their first month to identify which GLP-1 pathway variants may influence their individual response. Your dose may need to increase, but your monthly price remains constant—eliminating the cost-per-dose variability that brand-name pens create.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many weeks does one Ozempic pen last?
One Ozempic pen contains exactly four weekly injections, lasting precisely four weeks when used as prescribed. After four weeks, patients require a new pen, typically at a higher dose strength to continue their titration protocol.
What is the typical dose progression schedule for Ozempic?
Most patients begin with 0.25 mg weekly for four weeks, then advance to 0.5 mg weekly for another four weeks. Depending on tolerance and clinical goals, doses may escalate further to 1 mg or 2 mg weekly, with each advancement requiring a new pen purchase.
Why does compounded semaglutide cost less than brand-name Ozempic pens?
Compounded semaglutide from licensed 503A pharmacies bypasses brand-name manufacturing and distribution markups, reducing costs significantly. PlexusDx charges a flat monthly rate ($149) regardless of dose level, whereas brand-name pens often cost $900–$1,200 per pen and increase in price with higher dose strengths.
Can I adjust doses with an Ozempic pen, or are they fixed?
Ozempic pens deliver fixed, pre-determined doses—you cannot modify the amount within a pen. To change doses, you must purchase a new pen at a different strength level. Compounded semaglutide allows your prescriber to customize your exact dose each week, offering greater flexibility.
Does the Precision Peptide Genetic Test help predict how I'll respond to semaglutide?
Yes, PlexusDx's Precision Peptide Genetic Test examines key GLP-1 pathway variants (GLP1R rs6923761, GIPR rs1800437, and others) that influence your individual semaglutide response. This $99 add-on test maps 14 pathways and 150+ genetic insights, helping your clinician optimize your dose and medication choice for maximum weight loss efficacy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Which is More Effective for Weight Loss: Wegovy or Mounjaro?
How to Counter Ozempic Side Effects: Tips for a Smoother Journey